| Model Number |
M635TU90050 |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Codes |
Atrial Fibrillation (1729); High Blood Pressure/ Hypertension (1908); Pericardial Effusion (3271)
|
| Date of Event |
08/05/2026
|
|
Type of Reportable Event
|
Serious Injury
|
|
Event or Problem Description
|
|
It was reported that pericardial effusion occurred.A left atrial appendage (laa) closure procedure was being performed, and a watchman trusteer access system (was) was selected to be used.The patient had a windsock anatomy with posterior bend.During the procedure the physician performed transseptal puncture with the was and a pigtail catheter.The pigtail catheter was advanced into the appendage and removed for closure device insertion.During transesophageal echocardiography (tee) monitoring the physician noted more fluid being present around the appendage and was concerned for a pericardial effusion.The implanting physician placed the procedure on hold and had imaging physician sweep for size of effusion present.The effusion was seen around the left ventricle (lv) measuring one (1) cm in diameter, the patient was in atrial fibrillation (af) with heart rate elevated to about 100 bpm for the entire case, and the blood pressure (bp) was elevated to about 170/80.The physician determined to abort procedure due to uncertainty of post-operation care.The patient was monitored with tee for 20 minutes where vitals stabilized, the patient went into sinus rhythm, and the effusion never increased in size.After this time, the physician decided to close and did not administrate protamine.
|
| |
|
Event or Problem Description
|
|
It was reported that pericardial effusion occurred.A left atrial appendage (laa) closure procedure was being performed, and a watchman trusteer access system (was) was selected to be used.The patient had a windsock anatomy with posterior bend.During the procedure the physician performed transseptal puncture with the was and a pigtail catheter.The pigtail catheter was advanced into the appendage and removed for closure device insertion.During transesophageal echocardiography (tee) monitoring the physician noted more fluid being present around the appendage and was concerned for a pericardial effusion.The implanting physician placed the procedure on hold and had imaging physician sweep for size of effusion present.The effusion was seen around the left ventricle (lv) measuring one (1) cm in diameter, the patient was in atrial fibrillation (af) with heart rate elevated to about 100 bpm for the entire case, and the blood pressure (bp) was elevated to about 170/80.The physician determined to abort procedure due to uncertainty of post-operation care.The patient was monitored with tee for 20 minutes where vitals stabilized, the patient went into sinus rhythm, and the effusion never increased in size.After this time, the physician decided to close and did not administrate protamine.
|
| |
|
Additional Manufacturer Narrative
|
|
With all the available information, boston scientific (bsc) concludes:
device technical analysis
the watchman trusteer? access system was discarded; therefore, returned device analysis could not be completed.Device history record review
a review was completed of the device history records (dhr) for the watchman trusteer? access system, part # m635tu90050 batch # 0038614477.The dhr review confirmed that the device met all material, assembly, and performance specifications prior to distribution.Labeling review
there was no evidence to suggest that the device was used in a manner inconsistent with the labeling.Watchman trusteer? access system instructions for use (ifu) lists potential complications, risks and adverse events that may be associated with the use of this device which include pericardial effusion and arrhythmias (atrial fibrillation).Risk review
a risk review was completed and confirmed that the events of pericardial effusion and arrhythmias (atrial fibrillation) were defined in the risk documentation.Thes event types have been accounted for during product risk analysis to support acceptable risk benefit for the product.Investigation conclusion
based on a thorough review of the reported complaint, boston scientific has assigned an investigation conclusion code of no problem detected.
|
| |
|
Search Alerts/Recalls
|